Becton Dickinson (BDX) Capital Expenditures (2009 - 2026)
Becton Dickinson's (BDX) quarterly Capital Expenditures came in at $143.0 million in Q2 2026, down 12.8% year-over-year from $164.0 million in Q2 2025, and up 14.4% quarter-over-quarter from $125.0 million in Q1 2026.
Analysis
Becton Dickinson (BDX) Capital Expenditures (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Capital Expenditures for 18 consecutive years, with $143.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Capital Expenditures fell 12.8% year-over-year to $143.0 million in Q2 2026; TTM through Jun 2026 was $753.0 million, a 10.9% increase from a year earlier, with the FY2025 full-year figure at $760.0 million, up 4.83% from the prior year.
- Capital Expenditures was $143.0 million for Q2 2026 at Becton Dickinson, up from $125.0 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $377.0 million in Q3 2025 and troughed at $105.0 million in Q4 2024.
- A 5-year average of $195.8 million and a median of $180.0 million in 2023 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures slumped 44.23% in 2023 and climbed 27.36% in 2025, its largest moves.
- Over 5 years, Capital Expenditures stood at $208.0 million in 2022, then tumbled by 44.23% to $116.0 million in 2023, then dropped by 9.48% to $105.0 million in 2024, then advanced by 2.86% to $108.0 million in 2025, then jumped by 32.41% to $143.0 million in 2026.
- The last three Capital Expenditures figures came in at $143.0 million (Q2 2026), $125.0 million (Q1 2026), and $108.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 143.00 Mn |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 111.00 Mn |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 43.20 Mn |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 116.00 Mn |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | -67.01 Mn |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 1.07 Mn |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | 617,000.00 |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | 29,823.00 |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 143.00 Mn |
| Mar 31, 2026 | 125.00 Mn |
| Dec 31, 2025 | 108.00 Mn |
| Sep 30, 2025 | 377.00 Mn |
| Jun 30, 2025 | 164.00 Mn |
| Mar 31, 2025 | 114.00 Mn |
| Dec 31, 2024 | 105.00 Mn |
| Sep 30, 2024 | 296.00 Mn |
| Jun 30, 2024 | 179.00 Mn |
| Mar 31, 2024 | 134.00 Mn |
| Dec 31, 2023 | 116.00 Mn |
| Sep 30, 2023 | 294.00 Mn |
| Jun 30, 2023 | 191.00 Mn |
| Mar 31, 2023 | 181.00 Mn |
| Dec 31, 2022 | 208.00 Mn |
| Sep 30, 2022 | 315.00 Mn |
| Jun 30, 2022 | 253.00 Mn |
| Mar 31, 2022 | 222.00 Mn |
| Dec 31, 2021 | 183.00 Mn |
| Sep 30, 2021 | 452.00 Mn |